
Tirzepatide is a dual GIP/GLP-1 receptor agonist, engaging both incretin pathways simultaneously. Widely researched for its effects on glucose homeostasis, insulin sensitivity, appetite regulation, and body weight.
Sold strictly for laboratory and research purposes. Not for human or veterinary consumption.